Product Details:
Payment & Shipping Terms:
|
Source: | Rice Grain | Formulation: | OsrhbFGF Is Lyophilized With Mannitol As The Stabilizer |
---|---|---|---|
Endotoxin: | Less Than 1EU/ug | Molecular Weight: | 17KD |
Storage And Handling: | -20℃ For 24 Months | Production Type: | Recombinant Protein |
Highlight: | 17KD Human Fibroblast Growth Factor,Human Fibroblast Growth Factor,bFGF Biological Reagents |
High Purity Human Fibroblast Growth Factor BFGF Biological Reagents For Science Researches
Description
The biological effects of bFGF are divided into two parts, One side, bFGF has strong effects on cell division and proliferation activity to the fibroblasts, bone cells, chondrocytes, vascular endothelial cells, adrenal cortex and medulla, neurons and glial cells. On the other hand, bFGF is not only an important mitogenic factor, but also a morphogenesis and differentiation induction factor. Its main biological effects are: (1) as a vascular growth factor; (2) promote wound healing and tissue repair; (3) promote tissue regeneration; (4) involve in nerve regeneration and is a very important in vitro research tools.
Quick Details
Product Name | Recombinant Human Basic Fibroblast Growth Factor |
Source | Rice Grain (Oryza Sativa) |
Catalog No. | HYC005M01 |
Physical Appearance | White lyophilized powder |
Formulation | bFGF is lyophilized with mannitol as the stabilizer |
Purity | Greater than 95% as determined by SDS-PAGE and HPLC analysis. |
Endotoxin | Less than 1EU/ ug |
Restrictions | FOR RESEARCH, LABORATORY AND MANUFACTURE USE ONLY. NOT INTENDED FOR DIRECT USE ON HUMANS. |
Advantages
1. Wuhan Healthgen Biotechnology Corp. is a private company founded in 2006. We specialize in molecular pharmaceutical technology research and high-tech innovation-oriented product development, which is developing, manufacturing and marketing a series of recombinant proteins and growth factors by rice endosperm platform. We have 400 square meters of research center, in which 30% of the research personnels have doctoral degree and major in different directions of the research and development. Healthgen Biotech has strong capability in developing a series of biological products.
2. Healthgen Biotech recombinant bFGF(OsrhbFGF) is free of animal origin, which effectively avoid any potential risk of animal bacteria, prions, virus and contagious protein disease.
Supplemental Description
FGF basic is a member of the FGF family of at least 23 related mitogenic proteins which show 35-60% amino acid conservation. FGF acidic and basic, unlike the other members of the family, lack signal peptides and are apparently secreted by mechanisms other than the classical protein secretion pathway. FGF basic has been isolated from a number of sources, including neural tissue, pituitary, adrenal cortex, corpus luteum, and placenta. This factor contains four cysteine residues, but reduced FGF basic retains full biological activity, indicating that disulfide bonds are not required for this activity. A variety of forms of FGF basic are produced as a result of N-terminal extensions. These extensions affect localization of FGF basic in cellular compartments but do not affect biological activity. Binding of FGF to heparin or cell surface heparan sulfate proteoglycans is necessary for binding of FGF to high affinity FGF receptors. FGF acidic and basic appear to bind to the same high affinity receptors and show a similar range of biological activities. FGF basic stimulates the proliferation of all cells of mesodermal origin and many cells of neuroectodermal, ectodermal, and endodermal origin. FGF basic induces neuron differentiation, survival, and regeneration. FGF basic also modulates embryonic development and differentiation. These observed in vitro functions of FGF basic suggest FGF basic may play a role in vivo in the modulation of such normal processes as angiogenesis, wound healing and tissue repair, embryonic development and differentiation, and neuronal function and neural degeneration. Additionally, FGF basic may participate in the production of a variety of pathological conditions resulting from excessive cell proliferation and excessive angiogenesis.
Contact Person: Ms. Abby
Tel: +86-15071115810
Fax: 86-27-59403933-59416006